Tuberculosis Diagnostics Market Size [2021-2028] worth USD 2.87 Billion | exhibiting a CAGR of 4.9%

Posted on Aug 4 2022 5:36 AM

"Tuberculosis (TB) Diagnostics Market report provides an in-depth analysis of the market and focuses on aspects such as growth drivers, restraints, leading products, and major industry developments. It discusses the competitive landscape of the market and labels out leading players"

The global tuberculosis (TB) diagnostics market size is projected to witness remarkable growth in the forthcoming years. The rising geriatric population and the rising ubiquity of tuberculosis are anticipated to boost market growth. Fortune Business Insights™ has presented this information in an upcoming report, titled, “Tuberculosis (TB) Diagnostics Market, 2021-2028”. The tuberculosis (TB) diagnostics market is projected to gain steep momentum due to several reasons. For instance, the rising technological advancements in diagnostic tools due to the extensive research and development activities and the swift adoption of advanced diagnostic techniques are anticipated to fuel market growth.

Get Sample Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/102009

Key Players in the Global Tuberculosis (TB) Diagnostics Market are:

  • Hain Lifescience GmbH
  • Danaher
  • Thermo Fisher Scientific Inc.
  • BD
  • Oxford Immunotec USA Inc.
  • F-Hoffman-La Roche Ltd.
  • QIAGEN
  • Abbott

Drivers & Restraints-

Rising Worldwide TB Prevalence to Augment Market Growth

The increasing numbers of tuberculosis cases worldwide are expected to bolster global tuberculosis (TB) diagnostics market growth. Approximately 10 million people are diagnosed with tuberculosis per year worldwide, as per the World Health Organization (WHO). The rising geriatric population and the sedentary lifestyle of consumers are anticipated to fuel market growth. Moreover, the rising numbers of blood tests are expected to augment market growth.

The rising investments in research and developments activities by key players to develop advanced diagnostics are expected to foster market growth. Additionally, the launch of new diagnostic products is expected to bolster market growth. Lastly, the favorable government initiatives to spread awareness about diagnostics in surfacing markets and the swift adoption of advanced diagnostics in developing and developed economies are projected to surge market growth.

 

Purchase Full Report at -https://www.fortunebusinessinsights.com/checkout-page/102009

Asia Pacific to Dominate Global Market Backed by Rising Awareness of TB Diagnostics

Asia Pacific is expected to dominate in terms of the tuberculosis (TB) diagnostics market share. The growing instances of tuberculosis are expected to be the major growth drivers for the market. Additionally, the expanding consumer awareness regarding TB diagnostics and the swift diagnostic tools adoption is projected to stimulate market growth in the forthcoming years.

North America is projected to gain substantial growth in the global market. The rising investments in research and development activities to develop advanced TB diagnostics are anticipated to drive market growth. Europe is anticipated to gain considerable growth due to the growing tuberculosis prevalence in the region.

Moreover, This report focuses on Tuberculosis Diagnostics Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2029, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

Table Of Content:

  • Global Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Culture-based Diagnostics
      • Sputum Smear Microscopy
      • Rapid Molecular Diagnostics
      • Others
    • Market Analysis, Insights and Forecast – By End-user
      • Diagnostic Laboratories
      • Hospitals
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • North America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
      • Key Findings / Summary
      • Market Analysis, Insights and Forecast – By Type
        • Culture-based Diagnostics
        • Sputum Smear Microscopy
        • Rapid Molecular Diagnostics
        • Others
      • Market Analysis, Insights and Forecast – By End-user
        • Diagnostic Laboratories
        • Hospitals
      • Market Analysis, Insights and Forecast – By Country
        • S.
        • Canada
      • Europe Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
        • Key Findings / Summary
        • Market Analysis, Insights and Forecast – By Type
          • Culture-based Diagnostics
          • Sputum Smear Microscopy
          • Rapid Molecular Diagnostics
          • Others

TOC Continued……

Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/customization/tuberculosis-tb-diagnostics-market-102009

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Address:

Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

LinkedIn Facebook Twitter